FDA Inspection 542165 — Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. — FEI 3006031727

The FDA completed an inspection of Alexion Pharmaceuticals, Inc. on Oct 15, 2008 in New Haven, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 15, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Haven, CT (United States)